NutriBand (NTRB) EBT Margin (2018 - 2026)
NutriBand's (NTRB) quarterly EBT Margin came in at 201.26% in Q3 2026, up 12010.0% year-over-year from N/an in Q3 2025, and up 29.77% quarter-over-quarter from 286.56% in Q2 2026.
Analysis
NutriBand (NTRB) EBT Margin (2018 - 2026) Analysis & Trends
NutriBand has disclosed EBT Margin across 9 years of filings, most recently posting 201.26% for Q3 2026.
- In Q3 2026, EBT Margin rose 12010.0% year-over-year to 201.26%; the TTM figure through Jul 2026 stood at 430.43% (down 3213.0% YoY), while the FY2026 annual figure was 404.08%, up 8587.0% from the prior year.
- EBT Margin came in at 201.26% for Q3 2026 at NutriBand, up from 286.56% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 126.41% in Q3 2023 to a low of 1118.99% in Q4 2025.
- Average EBT Margin over 5 years is 370.37%, with a median of 286.56% recorded in 2026.
- Year-over-year, EBT Margin tumbled 90799 bps in 2025 and jumped 61716 bps in 2026.
- Over 5 years, EBT Margin stood at 174.03% in 2022, then plunged by 136 bps to 411.36% in 2023, then soared by 49 bps to 211.0% in 2024, then plunged by 430 bps to 1118.99% in 2025, then jumped by 82 bps to 201.26% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 201.26% in Q3 2026, 286.56% in Q2 2026, and 241.59% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.69 Bn | 2.15 Bn | -10.99% |
| 2 | Viatris | 18.87 Bn | 17.98 Bn | 1.46 Bn | -1.70% |
| 3 | Dr Reddys Laboratories | 9.74 Bn | 9.57 Bn | 396.53 Mn | 6.85% |
| 4 | Amneal Pharmaceuticals | 5.41 Bn | 5.28 Bn | 334.51 Mn | 8.92% |
| 5 | Bausch Health Companies | 2.30 Bn | 458.88 Mn | 2.10 Bn | 12.20% |
| 6 | Alvotech | 1.53 Bn | 1.39 Bn | 2.56 Mn | -121.92% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 13.94% |
| 8 | Amphastar Pharmaceuticals | 1.02 Bn | 726.78 Mn | 93.47 Mn | 20.96% |
| 9 | Fennec Pharmaceuticals | 393.81 Mn | 352.56 Mn | 17.15 Mn | 11.27% |
| 10 | NutriBand | 77.62 Mn | 74.19 Mn | 181,874.00 | -201.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -201.26% |
| Apr 30, 2026 | -286.56% |
| Jan 31, 2026 | -241.59% |
| Oct 31, 2025 | -1,118.99% |
| Jul 31, 2025 | -321.36% |
| Apr 30, 2025 | -208.09% |
| Jan 31, 2025 | -858.75% |
| Oct 31, 2024 | -211.00% |
| Jul 31, 2024 | -385.13% |
| Apr 30, 2024 | -464.61% |
| Jan 31, 2024 | -358.54% |
| Oct 31, 2023 | -411.36% |
| Jul 31, 2023 | -126.41% |
| Apr 30, 2023 | -212.87% |
| Jan 31, 2023 | -318.33% |
| Oct 31, 2022 | -174.03% |
| Jul 31, 2022 | -227.71% |
| Apr 30, 2022 | -144.37% |
| Jan 31, 2022 | -766.11% |
| Oct 31, 2021 | -555.34% |